Insiders Double Down on DENTSPLY SIRONA in Bold Buying Spree
TipRanks (Mon, 9-Mar 10:06 PM ET)
Top 10 healthcare stocks with highest dividend yield amid volatile markets
Seeking Alpha News (Mon, 9-Mar 10:19 AM ET)
Globe Newswire (Mon, 9-Mar 8:30 AM ET)
Dentsply Sirona’s Upcoming Conference Appearance Highlights Strategic Position in Dental Technology
Market Chameleon (Wed, 4-Mar 2:33 AM ET)
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026
Globe Newswire (Tue, 3-Mar 4:15 PM ET)
Market Chameleon (Fri, 27-Feb 6:18 AM ET)
Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook
Globe Newswire (Thu, 26-Feb 4:01 PM ET)
PRNewswire (Wed, 25-Feb 8:00 PM ET)
Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors
Globe Newswire (Tue, 24-Feb 4:30 PM ET)
Globe Newswire (Tue, 24-Feb 9:00 AM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of March 11, 2026, XRAY stock price climbed to $12.73 with 3,100,513 million shares trading.
XRAY has a beta of 1.16, meaning it tends to be more sensitive to market movements. XRAY has a correlation of 0.17 to the broad based SPY ETF.
XRAY has a market cap of $2.53 billion. This is considered a Mid Cap stock.
Last quarter Dentsply Sirona reported $961 million in Revenue and $.27 earnings per share. This beat revenue expectation by $37 million and missed earnings estimates by -$.01.
In the last 3 years, XRAY traded as high as $43.24 and as low as $9.85.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
XRAY has underperformed the market in the last year with a price return of -16.7% while the SPY ETF gained +21.9%. However, in the short term, XRAY had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.6% vs -1.3% return in SPY. But in the last 2 weeks, XRAY shares have been beat by the market, returning -3.1% compared to an SPY return of -1.6%.
XRAY support price is $12.20 and resistance is $13.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY shares will trade within this expected range on the day.